Loading...

Polyrizon Ltd.

PLRZ•NASDAQ
Healthcare
Biotechnology
$1.39
$-0.49(-26.06%)

Polyrizon Ltd. (PLRZ) Company Profile & Overview

Explore Polyrizon Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Polyrizon Ltd. (PLRZ) Company Profile & Overview

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

SectorHealthcare
IndustryBiotechnology
CEOTomer Izraeli

Contact Information

https://www.polyrizon-biotech.com
972 9 374 0120
5 Ha-Tidhar Street, Ra'anana, 4366507

Company Facts

2 Employees
IPO DateOct 29, 2024
CountryIL
Actively Trading

Frequently Asked Questions

;